10X Genomics, Inc. (TXG)

80.62 -17.12 (-17.52%) USD  |  NASDAQ  |  Oct 06, 16:00
80.62 0.00 (0.00%) After-Hours: 19:49
More

10X Genomics Cash from Investing (Quarterly) : -7.735M for June 30, 2026

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -7.735M
March 31, 2026 -1.311M
December 31, 2025 -1.805M
September 30, 2025 -8.801M
June 30, 2025 -0.939M
March 31, 2025 -1.893M
December 31, 2024 -51.59M
September 30, 2024 -3.618M
June 30, 2024 11.95M
March 31, 2024 10.63M
December 31, 2023 13.10M
September 30, 2023 4.90M
June 30, 2023 -4.462M
March 31, 2023 119.96M
Date Value
December 31, 2022 -33.17M
September 30, 2022 -32.63M
June 30, 2022 -27.53M
March 31, 2022 -257.56M
December 31, 2021 -27.62M
September 30, 2021 -20.23M
June 30, 2021 -14.57M
March 31, 2021 -44.32M
December 31, 2020 -22.27M
September 30, 2020 -1.31M
June 30, 2020 -6.739M
March 31, 2020 -8.079M
December 31, 2019 -6.581M
September 30, 2019 -13.68M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. -10.20M
Tempus AI, Inc. -11.09M
Personalis, Inc. 38.16M
Alamar Biosciences, Inc. (California) -120.80M
Beam Therapeutics, Inc. -9.875M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) 16.97M
Cash from Financing (Quarterly) 3.016M
Free Cash Flow 121.44M
Free Cash Flow Per Share (Quarterly) 0.1184
Free Cash Flow to Equity (Quarterly) 17.98M
Free Cash Flow to Firm (Quarterly) 15.39M
Free Cash Flow Yield 1.18%